Arrowhead Pharmaceuticals reported financial results for its fiscal year ended September 30, 2026, highlighting the commercial launch of REDEMPLO for familial chylomicronemia syndrome (FCS). The company reported 950 cumulative prescriptions since launch and announced that the FDA granted plozasiran entry into the STAR pilot program for severe hypertriglyceridemia, qualifying it for a 6-month priority review.
Term
FY2026
“Arrowhead has fundamentally changed over the past 12 months. Where there was once a company that relied solely on great scientific promise, there is now a company that is beginning to translate promise into real patient outcomes and the potential for durable shareholder value growth.”
Christopher Anzalone, Ph.D., President and CEO
“I believe we approach 2027 with the strongest combination of near-term commercial opportunity and scientific capability in our history.”
KIDZ AI Inc. reported a significant net loss of $7.34 million for the nine months ended September 30, 2026, compared to a $1.64 million loss in the prior year, driven by a $3.38 million fair value loss on crypto assets. Despite the loss, the company significantly strengthened its balance sheet through $10.74 million in private placement capital contributions and the conversion of $9.46 million in debt into equity.
Hartford Creative Group reported total revenues of $2,744,029 for fiscal 2026, a 35% increase driven by its advertising agency business, though net income fell 42% to $641,767 due to a significant credit loss expense and higher income taxes. The company is pivoting toward a mini-drama platform (YYYS App) and is pursuing an uplisting to the Nasdaq Capital Market to fund its estimated $2.0 million in upcoming capital requirements.
AXT, Inc. reported a significant revenue increase to $73.4 million for the third quarter of 2026, up from $28.0 million in the prior year, driven by improved gross margins and operational performance. The company swung to a net income of $25.7 million for the quarter compared to a net loss of $1.9 million in 2025, while its cash position strengthened substantially to $485.5 million following a major common stock issuance.
For the nine months ended September 30, 2026, Akari Therapeutics reported a net loss of $24.1 million, significantly higher than the $12.0 million loss in the prior year period, primarily driven by $12.1 million in impairment losses on goodwill and intangible assets. The company maintained a cash balance of $5.7 million and saw its total shareholders' equity decrease from $28.3 million to $17.5 million during the period.
Intellinetics, Inc. reported a decrease in total assets from $17.3 million at year-end 2025 to $16.7 million as of September 30, 2026. The company's accumulated deficit increased to $26.0 million, while deferred revenues grew significantly to $4.1 million, reflecting shifts in its software-as-a-service and recurring revenue model.
EagleRock Land, LLC is an emerging growth company focused on surface, resource, and water infrastructure assets in the Permian Basin. The filing highlights its recent initial public offering in May 2026 and outlines key operational risks including customer concentration, commodity price volatility, and reliance on surface use agreements.
Yale Transaction Finders, Inc. is a shell company with no revenue, reporting a net loss of $23,521 for the nine months ended September 30, 2026. The company faces substantial doubt about its ability to continue as a going concern, characterized by an accumulated deficit of $1,421,109 and reliance on related-party financing.
SELLAS Life Sciences Group reported a net loss of $10.1 million for the third quarter of 2026, compared to $6.8 million in the prior year period, driven by increased research and development expenses. The company strengthened its balance sheet significantly, ending the period with $134.7 million in cash and cash equivalents following substantial warrant exercises during the nine months ended September 30, 2026.
Kodiak Sciences reported Q3 2026 financial results and provided updates on its late-stage retinal pipeline, including positive Phase 3 DAYBREAK results for Zenkuda and tabirafusp-ted. The company plans to submit a multi-indication BLA for Zenkuda by the end of 2026 and expects pivotal data for KSI-101 in December 2026.
“We believe Kodiak stands apart in retina, with three late-stage assets that together give us the opportunity to build a leading retinal medicines company.”
Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences
“Looking ahead, we expect to announce the first Phase 3 KSI-101 results in December and, if successful, plan to file a BLA for KSI-101 in the second quarter of 2027. We are also on track to submit the multi-indication BLA for Zenkuda by year end, supported by five successful Phase 3 studies.”
Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences
Stone Point Credit Corp reported a net increase in net assets from operations of $60.2 million for the nine months ended September 30, 2026, down from $95.2 million in the prior year period. The decrease was primarily driven by $29.6 million in net unrealized depreciation, while net investment income remained relatively stable at $89.3 million.
River Financial Corp reported total assets of $4.09 billion as of September 30, 2026, an increase from $3.79 billion at year-end 2025. The growth was primarily driven by a rise in net loans to $2.89 billion and an increase in total deposits to $3.61 billion.
For the nine months ended September 30, 2026, Brookfield Real Estate Income Trust reported total revenues of $121.4 million, up from $107.8 million in the prior year period. Net income for the nine-month period was $8.7 million, though the company recorded a net loss attributable to stockholders of $0.37 million after accounting for non-controlling interests.
Fundrise eREIT, LLC reported a significant net loss of $11.3 million for Q3 2026, compared to a net income of $5.7 million in the prior year, primarily driven by losses in equity method investees. The company underwent a major merger during the period, resulting in total assets increasing from $274.9 million at year-end 2025 to $791.6 million by September 30, 2026.
For the nine months ended September 30, 2026, the Federal Home Loan Bank of Dallas reported net income of $356.2 million, a decrease from $456.3 million in the prior year period, primarily driven by lower net interest income. Total assets decreased slightly to $106.8 billion from $108.5 billion at year-end 2025, while total capital increased to $6.87 billion.
Prosper Marketplace, Inc. and Prosper Funding LLC filed a combined Form 10-Q for the period ending September 30, 2026, reporting 79,938,949 shares of PMI common stock outstanding. The filing highlights significant risks including the impact of a September 2025 cybersecurity incident and the termination of several variable interest entities such as PMIT 2023-1 and PMIT 2024-1.
Prosper Marketplace, Inc. reported cash and cash equivalents of $74.1 million as of September 30, 2026, an increase from $46.8 million at year-end 2025. The filing highlights a significant cybersecurity incident from September 2025 and notes that there were 79,938,949 shares of common stock outstanding as of November 9, 2026.
For the nine months ended September 30, 2026, Lord Abbett Private Credit Fund S reported total investment income of $28.63 million and net investment income of $12.69 million. Total net assets grew to $226.77 million from $127.42 million at the end of 2025, driven by significant capital raises, though the net asset value per share decreased slightly from $25.11 to $24.68.
RREEF Property Trust reported a net loss of $2.6 million for the quarter ended September 30, 2026, compared to a net income of $22.1 million in the prior year period, primarily due to a $8.3 million impairment provision and lower gains on real estate sales. Total assets decreased to $298.5 million from $372.5 million at year-end 2025 as the company continued to sell real estate assets and pay down debt.
Fortress Credit Realty Income Trust reported a significant increase in its share count across multiple classes as of November 12, 2026, with Class B and Class J-1 shares being the largest components. The filing highlights risks related to interest rate fluctuations, real estate market conditions, and the company's status as an emerging growth company and non-accelerated filer.
For the nine months ended September 30, 2026, Lord Abbett Private Credit Fund reported total investment income of $111.2 million and net investment income of $58.7 million. Total net assets grew to $869.4 million from $528.0 million at the end of 2025, despite a net decrease in unrealized appreciation of $7.0 million during the period.
Oglethorpe Power Corporation reported total assets of $17.85 billion as of September 30, 2026, with significant growth in construction work in progress to $1.46 billion. The company, a membership corporation with no outstanding equity securities, saw its patronage capital and membership fees increase to $1.47 billion while long-term debt rose to $12.55 billion.
Where Food Comes From, Inc. reported total revenues of $19.3 million for the nine months ended September 30, 2026, a slight increase from $18.9 million in the prior year. While income from operations grew to $1.9 million, net income decreased to $1.3 million compared to $1.7 million in 2025, primarily due to a significant one-time gain on the sale of assets in the previous year.
For the nine months ended September 30, 2026, Franklin BSP Capital Corp reported total investment income of $291.9 million and net investment income of $103.6 million. Net assets attributable to common stock decreased to $1.795 billion, or $13.42 per share, primarily due to realized losses and common stockholder distributions exceeding net investment income.
Star Mountain Lower Middle-Market Capital Corp. reported total investment income of $29.19 million for the nine months ended September 30, 2026, a slight decrease from $30.34 million in the prior year period. Net assets decreased to $228.29 million from $237.23 million at year-end 2025, primarily driven by $16.86 million in distributions and $7.80 million in realized losses, partially offset by $11.47 million in unrealized appreciation.
IEH Corp reported a significant turnaround for the six months ended September 30, 2026, with revenue increasing to $20.7 million from $13.4 million in the prior year. The company achieved a net income of $2.0 million compared to a net loss of $0.7 million, driven by higher sales volume and a benefit from income taxes.
For the nine months ended September 30, 2026, the Federal Home Loan Bank of Boston reported net income of $155.9 million, a decrease from $170.0 million in the prior year period. Total assets grew to $70.3 billion, driven by increases in interest-bearing deposits and mortgage loans held for portfolio, while net interest income remained relatively stable at $281.1 million.
Kaanapali Land LLC reported a significant increase in net income for the nine months ended September 30, 2026, reaching $12.8 million compared to a $2.0 million loss in the prior year, primarily driven by the sale of the Pioneer Mill site and insurance recoveries. Total revenues surged to $21.7 million from $1.3 million year-over-year, while the company also benefited from $4.9 million in insurance gains related to wildfire damage.
Third Point Private Capital Partners reported total investment income of $6.2 million for the nine months ended September 30, 2026, primarily driven by interest income from non-controlled investments. The fund achieved a net investment income of approximately $3.0 million for the period, with a net asset value per share of $27.06 as of the reporting date.
VistaOne, L.P. reported a net investment loss of $28.9 million for the nine months ended September 30, 2026, as investment income was offset by significant performance participation allocations and management fees. However, the fund saw substantial growth in total assets to $1.89 billion, driven by $101.9 million in net unrealized appreciation on investments and increased unit issuances across multiple classes.